Physicians' Academy for Cardiovascular Education

Agenda Topics ▼On-demand Online-CME Podcasts News ▼Programs Slides ▼About

Anticoagulation ▼Diabetes & CVD ▼Heart Failure ▼Kidney disease & CVD ▼Lipids ▼

HoFH

Feb. 8, 2015

Share this page with your colleagues and friends:

Continue reading:

Anticoagulation

No indication for oral anticoagulation after TAVI: SAPT outperforms DAPT and DOAC-based regimens

Literature - Mar. 20, 2023 - Guedeney P, et al. - Eur Heart J Cardiovasc Pharmacother. 2023

Longer DOAC treatment reduces risk of recurrent VTE with no increased bleeding risk

Literature - Feb. 13, 2023 - Ageno W, et al. - BMJ. 2022

Monotherapy with oral anticoagulant beyond 1 year after PCI as effective and safe as dual therapy in stable AF patients

Literature - Dec. 5, 2022 - Jensen T, et al. - Eur Heart J Cardiovasc Pharmacother. 2022

Diabetes & CVD

Beneficial effects of nonsteroidal MRA on mortality in patients with CKD and T2DM

Literature - Mar. 15, 2023 - Filippatos G, et al. - Eur Heart J Cardiovasc Pharmacother. 2023

Multifaceted intervention improves prescription of therapies in T2DM and ASCVD

News - Mar. 10, 2023

Expanded indication for non-steroidal MRA in EU for broad range of patients with CKD and T2DM

News - Mar. 1, 2023

Heart Failure

Well-designed EHR tools can improve prescribing of MRA in HFrEF

3' education - Mar. 21, 2023 - Amrita Mukhopadhyay, MD

Treatment effects of ARNI in HF independent of eGFR decline during run-in phase

Literature - Mar. 20, 2023 - Chatur S, Claggett BL, McCausland FR, et al. - J Am Coll Cardiol. 2023

SGLT2i improves CV outcomes in patients with HFmrEF or HFpEF regardless of kidney function

Literature - Mar. 14, 2023 - Mc Causland FR, et al. - JAMA Cardiol. 2023

Kidney disease & CVD

IL-6 inhibition reduces neutrophil-lymphocyte ratio in patients with CKD and elevated hsCRP

Literature - Mar. 22, 2023 - Adamstein NH, et al. - JAMA Cardiol. 2023

A call to action: optimizing treatment in CKD

10' education - Mar. 22, 2023 - Prof. Meg Jardine, MD, PhD

Treatment effects of ARNI in HF independent of eGFR decline during run-in phase

Literature - Mar. 20, 2023 - Chatur S, Claggett BL, McCausland FR, et al. - J Am Coll Cardiol. 2023

Lipids

Do personalized reminders to clinicians result in higher use of high-intensity statins?

3' education - Mar. 23, 2023 - Prof. Salim Virani, MD, PhD

Initiating PCSK9 mAb after ACS: When and how to start?

10' education - Mar. 22, 2023 - Prof. Wouter Jukema, MD, PhD and Prof. Pasquale Perrone-Filardi, MD, PhD

Beneficial effects of PCSK9i on CV events depend on both hsCRP and Lp(a) levels

Literature - Mar. 21, 2023 - Schwartz GG, et al. - J Am Coll Cardiol. 2022

© 2006 - 2023 pace-cme.org - About